3 hours ago
RingConn smart ring receives FDA clearance for blood oxygen monitoring
What's happening
SignalsMonitor is following this as a technology story. The Scotsman and Yorkshire Post are the outlets attached to this story. The first report grouped here was at 12 Oct 2026, 09:42 UTC. 2 material updates are listed in the timeline. The headline in use is “RingConn smart ring receives FDA clearance for blood oxygen monitoring”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Shenzhen-based wearable technology company RingConn has received US Food and Drug Administration (FDA) 510(k) clearance for non-invasive blood oxygen (SpO2) measurement on its Smart Ring.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Yorkshire Post
RingConn smart ring receives FDA clearance for blood oxygen monitoring
- Picked up by The Scotsman
RingConn smart ring receives FDA clearance for blood oxygen monitoring
Same story, different outlets
2 headlinesEach line is that outlet's headline. The article stays on the publisher's site.